(1 - 17 from 17
)
Molecular Partners CEO considers partners, capital hike to ...
www.reuters.com
May 24, — ... one of its pipeline assets to refill the Swiss biotechnology company's coffers by 2019, Chief Executive Patrick Amstutz told Reuters. › article
Covid ist nicht mehr dringlich - Biotech-Branche - SRF
www.srf.ch
May 13, — Patrick Amstutz, Molecular Partners: «An der Börse sieht man, dass Geld hinausfliesst.» Aus News-Clip vom abspielen. Laufzeit › News › Wirtschaft
Swiss Biotech Association Strengthens Its Board of Directors and ...www.b3cnewswire.com › swiss-biotech-association-strengthens-its-board-o...
www.b3cnewswire.com
Sep 27, · The Swiss Biotech Association appointed Dr. Patrick Amstutz (CEO of Molecular Partners) and Filippo Riva (CEO of Humabs Biomed) at its ...
sorted by relevance / date